GLP-3 RT

GLP-3 RT is a next-generation triple receptor agonist synthesized for advanced laboratory research. Engineered to engage GLP-1, GIP, and glucagon receptors simultaneously, it enables researchers to investigate the complex, interconnected signaling pathways that govern metabolic regulation, energy expenditure, and glucose homeostasis at a level not achievable with mono- or dual-agonist compounds. The compound's tripartite receptor activity makes it a powerful model for studying the additive and synergistic effects of combined incretin and glucagon pathway activation. Research applications include in vitro receptor binding studies, in vivo metabolic phenotyping, and mechanistic investigation of multi-receptor pharmacology. Available in 10mg, 20mg, 30mg, and 60mg vials to suit a broad range of experimental scales. Each batch is independently tested and supplied with a Certificate of Analysis (COA) confirming identity, purity, and concentration. For research use only. Not intended for human or veterinary use.